An Observational Study of Octreotide Subcutaneous Depot in Patients With Acromegaly

A Multi-Center, Multinational, Observational Study of Octreotide Subcutaneous Depot for the Treatment of Patients With Acromegaly

The purpose of this study is to collect long-term (up to two years) safety and effectiveness of octreotide subcutaneous depot in patients with acromegaly in the real-world setting.

Inclusion Criteria:

• Have started or will be starting treatment with octreotide SC depot for acromegaly

Exclusion Criteria:

• Have started or will be starting treatment with octreotide SC depot for other conditions not related to acromegaly
• Currently taking part in an interventional clinical trial or is still within a 30-day washout period from the end of taking part in an interventional clinical trial.